|
Panacea Biotec has emerged as a leading health management company of India addressing both areas of concern. Panacea Biotec manufactures and markets branded vaccines, pharmaceutical and biotechnology-based products of international quality. The manufacturing plant for Vaccines in the capital of India, New Delhi is prequalified by WHO for supply to U.N. Agencies. Panacea Biotec meets most of the state requirements of OPV under Pulse Polio Program in India. It is equipped with latest and most modern machinery, equipments and infrastructure to roll out products as per company's stringent Quality Policy. Panacea Biotec forayed into Pain Management, Organ Transplant & Diabetes Management segments by introducing the unique Non- Steroidal Anti Inflammatory Drug -Nimulid (Nimesulide), Panimun Bioral (Cyclosporin) and Glizid (Gliclazide) respectively. Panacea Biotec is only one of the few health management companies which is strategically poised to take up new challenges in the post WTO era. Today Panacea Biotec has more than 150 scientists in 3 state of the art R&D centers in the field of Pharmaceuticals, Biopharmaceuticals & Vaccines.
|
